These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37935635)

  • 1. Endpoint adjudication in cardiovascular clinical trials.
    Khan MS; Usman MS; Van Spall HGC; Greene SJ; Baqal O; Felker GM; Bhatt DL; Januzzi JL; Butler J
    Eur Heart J; 2023 Dec; 44(46):4835-4846. PubMed ID: 37935635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cardiovascular clinical events and impact of event adjudication on the treatment effect of darapladib versus placebo in patients with stable coronary heart disease: Insights from the STABILITY trial.
    Held C; White HD; Stewart RAH; Davies R; Sampson S; Chiswell K; Silverstein A; Lopes RD; Heldestad U; Budaj A; Mahaffey KW; Wallentin L;
    Am Heart J; 2019 Feb; 208():65-73. PubMed ID: 30572273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjudication of cardiovascular events in patients with chronic obstructive pulmonary disease: SUMMIT trial.
    Wise RA; Anderson JA; Amarenco P; Cowans NJ; Crim C; Denvir MA; Gomez CR; Jones MP; Morris A; Niewoehner D; Yates JC
    Clin Trials; 2020 Aug; 17(4):430-436. PubMed ID: 32441114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
    Gaba P; Bhatt DL; Giugliano RP; Steg PG; Miller M; Brinton EA; Jacobson TA; Ketchum SB; Juliano RA; Jiao L; Doyle RT; Granowitz C; Tardif JC; Ballantyne CM; Pinto DS; Budoff MJ; Gibson CM
    J Am Coll Cardiol; 2021 Oct; 78(15):1525-1537. PubMed ID: 34620410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).
    Leonardi S; Franzone A; Piccolo R; McFadden E; Vranckx P; Serruys P; Benit E; Liebetrau C; Janssens L; Ferrario M; Zurakowski A; van Geuns RJ; Dominici M; Huber K; Slagboom T; Buszman P; Bolognese L; Tumscitz C; Bryniarski K; Aminian A; Vrolix M; Petrov I; Garg S; Naber C; Prokopczuk J; Hamm C; Steg G; Heg D; Juni P; Windecker S; Valgimigli M
    BMJ Open; 2019 Mar; 9(3):e026053. PubMed ID: 30852547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.
    Easton JD; Denison H; Evans SR; Knutsson M; Amarenco P; Albers GW; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KL; Johnston SC;
    Int J Stroke; 2019 Dec; 14(9):908-914. PubMed ID: 31092152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation.
    Vranckx P; McFadden E; Cutlip DE; Mehran R; Swart M; Kint PP; Zijlstra F; Silber S; Windecker S; Serruys PW
    Contemp Clin Trials; 2013 Jan; 34(1):53-9. PubMed ID: 22975439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
    Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
    JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.
    Pogue J; Walter SD; Yusuf S
    Clin Trials; 2009 Jun; 6(3):239-51. PubMed ID: 19528133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial.
    Hata J; Arima H; Zoungas S; Fulcher G; Pollock C; Adams M; Watson J; Joshi R; Kengne AP; Ninomiya T; Anderson C; Woodward M; Patel A; Mancia G; Poulter N; MacMahon S; Chalmers J; Neal B;
    PLoS One; 2013; 8(2):e55807. PubMed ID: 23390553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY.
    Leonardi S; Branca M; Franzone A; McFadden E; Piccolo R; Jüni P; Vranckx P; Steg PG; Serruys PW; Benit E; Liebetrau C; Janssens L; Ferrario M; Zurakowski A; Diletti R; Dominici M; Huber K; Slagboom T; Buszman P; Bolognese L; Tumscitz C; Bryniarski K; Aminian A; Vrolix M; Petrov I; Garg S; Naber C; Prokopczuk J; Hamm C; Heg D; Windecker S; Valgimigli M
    Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e006581. PubMed ID: 33535773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hybrid automated event adjudication system for clinical trials.
    Yuan F; Bosch J; Eikelboom J; Dagenais GR; Connolly S; Belanger J; Marsden T; Tang C; Swaminathan B; Renters M; Dyal L; Bangdiwala SI
    Clin Trials; 2023 Apr; 20(2):166-175. PubMed ID: 36734212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A web-based endpoint adjudication system for interim analyses in clinical trials.
    Nolen TL; Dimmick BF; Ostrosky-Zeichner L; Kendrick AS; Sable C; Ngai A; Wallace D
    Clin Trials; 2009 Feb; 6(1):60-6. PubMed ID: 19254936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons.
    Kristensen AMD; Pareek M; Kragholm KH; Sehested TSG; Olsen MH; Prescott EB
    Cardiology; 2022; 147(3):235-247. PubMed ID: 35537418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experience.
    Kirwan BA; Lubsen J; de Brouwer S; Danchin N; Battler A; Bayes de Luna A; Dunselman PH; Glasser S; Koudstaal PJ; Sutton G; van Dalen FJ; Poole-Wilson PA;
    Contemp Clin Trials; 2007 Nov; 28(6):720-9. PubMed ID: 17509947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of Cardiovascular Trial Outcome Ascertainment and Treatment Effect Estimates from Routine Health Data: A Systematic Review and Meta-Analysis.
    Rodrigues C; Odutayo A; Patel S; Agarwal A; da Costa BR; Lin E; Yeh RW; Jüni P; Goodman SG; Farkouh ME; Udell JA
    Circ Cardiovasc Qual Outcomes; 2021 May; 14(5):e007903. PubMed ID: 33993728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial.
    Mahaffey KW; Held C; Wojdyla DM; James SK; Katus HA; Husted S; Steg PG; Cannon CP; Becker RC; Storey RF; Khurmi NS; Nicolau JC; Yu CM; Ardissino D; Budaj A; Morais J; Montgomery D; Himmelmann A; Harrington RA; Wallentin L;
    J Am Coll Cardiol; 2014 Apr; 63(15):1493-9. PubMed ID: 24561148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Clinically Adjudicated Versus Flow-Based Adjudication of Revascularization Events in Randomized Controlled Trials.
    Wang R; Kawashima H; Hara H; Gao C; Ono M; Takahashi K; Tu S; Soliman O; Garg S; van Geuns RJ; Tao L; Wijns W; Onuma Y; Serruys PW
    Circ Cardiovasc Qual Outcomes; 2021 Nov; 14(11):e008055. PubMed ID: 34666500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials: Experience of the SHIFT Heart Failure Study.
    Tyl B; Lopez Sendon J; Borer JS; Lopez De Sa E; Lerebours G; Varin C; De Montigny A; Pannaux M; Komajda M
    Circ Heart Fail; 2020 Jul; 13(7):e006720. PubMed ID: 32580655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.